1. Home
  2. NFG vs RGEN Comparison

NFG vs RGEN Comparison

Compare NFG & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NFG
  • RGEN
  • Stock Information
  • Founded
  • NFG 1902
  • RGEN 1981
  • Country
  • NFG United States
  • RGEN United States
  • Employees
  • NFG N/A
  • RGEN N/A
  • Industry
  • NFG Oil/Gas Transmission
  • RGEN Medical/Dental Instruments
  • Sector
  • NFG Utilities
  • RGEN Health Care
  • Exchange
  • NFG Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • NFG 7.0B
  • RGEN 8.0B
  • IPO Year
  • NFG N/A
  • RGEN N/A
  • Fundamental
  • Price
  • NFG $80.41
  • RGEN $133.72
  • Analyst Decision
  • NFG Buy
  • RGEN Buy
  • Analyst Count
  • NFG 2
  • RGEN 12
  • Target Price
  • NFG $81.00
  • RGEN $172.67
  • AVG Volume (30 Days)
  • NFG 681.0K
  • RGEN 863.9K
  • Earning Date
  • NFG 04-30-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • NFG 2.56%
  • RGEN N/A
  • EPS Growth
  • NFG N/A
  • RGEN N/A
  • EPS
  • NFG 0.43
  • RGEN N/A
  • Revenue
  • NFG $2,068,941,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • NFG $30.50
  • RGEN $13.93
  • Revenue Next Year
  • NFG $10.32
  • RGEN $14.35
  • P/E Ratio
  • NFG $188.75
  • RGEN N/A
  • Revenue Growth
  • NFG 5.94
  • RGEN 4.88
  • 52 Week Low
  • NFG $53.03
  • RGEN $102.97
  • 52 Week High
  • NFG $82.70
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • NFG 55.50
  • RGEN 49.67
  • Support Level
  • NFG $75.73
  • RGEN $123.10
  • Resistance Level
  • NFG $83.35
  • RGEN $143.56
  • Average True Range (ATR)
  • NFG 1.79
  • RGEN 7.12
  • MACD
  • NFG 0.18
  • RGEN -0.81
  • Stochastic Oscillator
  • NFG 61.35
  • RGEN 41.10

About NFG National Fuel Gas Company

National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: